What’s the Evidence Based on Healthy Super Agers?

As the global elderly population is projected to reach approximately 46.4% by 2070, with nations like South Korea rapidly transitioning into super-aged societies, research into age-related cognitive decline and resilience has grown increasingly critical. The concept of “Superagers,” individuals aged 65 and older who maintain cognitive abilities comparable to those decades younger, offers a promising framework for investigating cognitive reserve and resilience against neurodegeneration. Lee, et al., conducted a pioneering study aimed at identifying the biological underpinnings of Superager status using both traditional statistical analyses and advanced machine learning techniques. While conventional methods detected significant differences in only four biomarkers, machine learning-based feature selection expanded the biomarker panel to 15, indicating a more complex biological profile underlying exceptional cognitive aging. Importantly, the study employed Shapley Additive Explanations (SHAP) to enhance model interpretability, demonstrating how specific blood-based biomarkers contribute to cognitive performance. These findings underscore the potential of using routine blood tests to not only assess cognitive function but also to predict and classify Superager status in healthy elderly populations. The study offers clinically significant insights and establishes a foundation for future explorations into the biological mechanisms that support cognitive resilience in aging populations.